KORU Medical Systems, Inc.

KORU Medical Systems, Inc. manufactures and distributes subcutaneous infusion systems designed for patient autonomy and home-based therapeutic administration. The company's primary product portfolio includes the Freedom™ Infusion System family—specifically the Freedom60® and FreedomEDGE® syringe infusion pumps—along with complementary disposable accessories including High-Flo™ Subcutaneous Safety Needle Sets and Precision™ Flow Rate Tubing. These devices are FDA-cleared (510(k) summaries K200176 for Freedom and K214045 for FreedomEDGE) and indicated for subcutaneous delivery of immunoglobulin and other therapeutics, including RYSTIGGO® in the US market. KORU's systems are designed to enable patient administration of medicine in alignment with the body's natural physiological processes while allowing treatment in home and non-clinical settings. The company provides clinical training, nursing support, and patient education resources to ensure safe device use. Target markets include patients requiring chronic subcutaneous infusion therapy, immunology practices, hospital infusion centers, and home healthcare providers. KORU emphasizes patient empowerment, ease of use, and compatibility with established subcutaneous delivery protocols.